p63基因及其在宫颈癌中的研究进展
Research Progress of p63 Gene and Its Role in Cervical Cancer
DOI: 10.12677/ACM.2022.124471, PDF,   
作者: 薛秀秀：青海大学研究生院，青海 西宁；沙仁高娃：青海大学附属医院，青海 西宁
关键词: p63；宫颈癌；HPV E6；HPV E7；CIN；p63； Cervical Cancer； HPV E6； HPV E7； CIN
摘要: 转录因子p63是p53家族成员之一，在调节母体生殖和基因组完整性以及表皮发育、增殖潜能、分化、细胞死亡和存活中起重要作用。在女性生殖系统中，宫颈癌严重威胁着妇女的生命健康。现有研究认为细胞的癌变是抑癌基因和癌基因之间功能失衡所致。p63在宫颈癌组织及癌旁组织的差异表达，表明其在宫颈癌中具有非同寻常的作用。如今，p63在癌症中的作用存在很大争议。为此，本文就p63基因、结构与功能及其与宫颈癌的相互作用关系研究进展作一综述。
Abstract: Transcription factor p63, a member of the p53 family, plays an important role in regulating ma-ternal reproduction and genome integrity as well as epidermal development, proliferation potential, differentiation, cell death and survival. In female reproductive system, cervical cancer is a serious threat to women’s life and health. Current studies suggest that the canceration of cells is caused by the dysfunction between tumor suppressor genes and oncogenes. The differential expression of p63 in cervical and paracancer tissues indicated that p63 plays an extraordinary role in cervical cancer. Today, the role of p63 in cancer is highly controversial. In this review, the structure and function of p63 gene and its interaction with cervical cancer were reviewed.
文章引用：薛秀秀, 沙仁高娃. p63基因及其在宫颈癌中的研究进展[J]. 临床医学进展, 2022, 12(4): 3265-3271. https://doi.org/10.12677/ACM.2022.124471

参考文献

[1] Gunaratne, P.H., Pan, Y., Rao, A.K., Lin, C., Hernandez-Herrera, A., Liang, K., et al. (2019) Activating p53 Family Member TAp63: A Novel Therapeutic Strategy for Targeting p53-Altered Tumors. Cancer, 125, 2409-2422. [Google Scholar] [CrossRef] [PubMed]
[2] Costanzo, A., Pediconi, N., Narcisi, A., Guerrieri, F., Belloni, L., Fausti, F., Botti, E. and Levrero, M. (2014) TP63 and TP73 in Cancer, an Unresolved “Family” Puzzle of Complexity, Re-dundancy and Hierarchy. FEBS Letters, 588, 2590-2599. [Google Scholar] [CrossRef] [PubMed]
[3] Gonfloni, S., Di Tella, L., Caldarola, S., Cannata, S.M., Klinger, F.G., Di Bartolomeo, C., et al. (2009) Inhibition of the c-Abl-TAp63 Pathway Protects Mouse Oocytes from Chemotherapy-Induced Death. Nature Medicine, 15, 1179-1185. [Google Scholar] [CrossRef] [PubMed]
[4] Yang, A., Kaghad, M., Wang, Y.M., Gillett, E., Fleming, M.D., Dötsch, V., et al. (1998) p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities. Molecular Cell, 2, 305-316. [Google Scholar] [CrossRef] 
[5] Murray-Zmijewski, F., Lane, D.P. and Bourdon, J.-C. (2006) P53/P63/P73 Isoforms: an Orchestra of Isoforms to Harmonise Cell Differentiation and Response to Stress. Cell Death & Differentiation, 13, 962-972. [Google Scholar] [CrossRef] [PubMed]
[6] 王建力, 陈莉, 王杜兰, 曹晓蕾. P63在皮肤鳞状细胞癌中的表达[J]. 南通医学院学报, 2001, 24(4): 339-340.
[7] Sankaranarayanan, R., Swaminathan, R., Brenner, H., Chen, K., Chia, K.S., Chen, J.G, et al. (2010) Cancer Survival in Africa, Asia, and Central America: A Population-Based Study. The Lancet Oncology, 11, 165-173.
[8] Small, W., Bacon, M.A., Bajaj, A., Chuang, L.T., Fisher, B.J., Harkenrider, M.M., et al. (2017) Cervical Cancer: A Global Health Crisis. Cancer, 123, 2404-2412. [Google Scholar] [CrossRef] [PubMed]
[9] Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. [Google Scholar] [CrossRef] [PubMed]
[10] Parkhurst, J.O. and Vulimiri, M. (2013) Cervical Cancer and the Global Health Agenda: Insights from Multiple Policy-Analysis Frameworks. Global Public Health, 8, 1093-1108. [Google Scholar] [CrossRef] [PubMed]
[11] Deligeoroglou, E., Giannouli, A., Athanasopoulos, N., Karountzos, V., Vatopoulou, A., Dimopoulos, K., et al. (2013) HPV Infection: Immunological Aspects and Their Utility in Future Therapy. Infectious Diseases in Obstetrics and Gynecolog, 2013, Article ID: 540850. [Google Scholar] [CrossRef] [PubMed]
[12] Mai, M., Huang, H., Reed, C., Qian, C., Smith, J.S., Alderete, B., et al. (1998) Genomic Organization and Mutation Analysis of p73 in Oligodendrogliomas with Chromosome 1 P-arm Dele-tions. Genomics, 51, 359-363. [Google Scholar] [CrossRef] [PubMed]
[13] 杨宇, 许庆, 张瑜. p63在宫颈癌中的研究进展[J]. 生命科学研究, 2013, 17(4): 359-363.
[14] Mangiulli, M., Valletti, A., Caratozzolo, M.F., Tullo, A., Sbisà, E., Pesole, G., et al. (2009) Identification and Functional Characterization of Two New Transcriptional Variants of the Human p63 Gene. Nucleic Acids Research, 37, 6092-6104. [Google Scholar] [CrossRef] [PubMed]
[15] Kawasaki, S., Tanioka, H., Yamasaki, K., Connon, C.J. and Kinoshita, S. (2006) Expression and Tissue Distribution of p63 Isoforms in Human Ocular Surface Pithelia. Experimental Eye Research, 82, 293-299. [Google Scholar] [CrossRef] [PubMed]
[16] Su, X., Chakravarti, D. and Flores, E.R. (2013) p63 Steps into the Limelight: Crucial Roles in the Suppression of Tumorigenesis and Metastasis. Nature Reviews Cancerr, 13, 136-143. [Google Scholar] [CrossRef] [PubMed]
[17] 袁丽丽, 李树峰, 严云勤. p53家族新成员p63基因[J]. 肿瘤学杂志, 2004, 10(6): 447-449.
[18] Cervo, P.R., Lena, A.M., Nicoloso, M., Rossi, S., Mancini, M., Zhou, H., et al. (2012) p63-MicroRNA Feedback in Keratinocyte Senescence. Proceedings of the National Academy of Sciences of the United States of America, 109, 1133-1138. [Google Scholar] [CrossRef] [PubMed]
[19] Soares, E. and Zhou, H. (2018) Master Regulatory Role of p63 in Epidermal Development and Disease. Cellular and Molecular Life Science, 75, 1179-1190. [Google Scholar] [CrossRef] [PubMed]
[20] Mills, A.A., Zheng, B., Wang, X.J., Vogel, H., Roop, D.R., Bradley, A., et al. (1999) p63 Is a p53 Homologue Required for Limb and Epidermal Morphogenesis. Nature, 398, 708-713. [Google Scholar] [CrossRef] [PubMed]
[21] Mcgrath, J.A., Duijf, P.H., Doetseh, V., Irvine, A.D., de Waal, R., Vanmolkot, K.R., et al. (2001) Hay-Wells Syndromeis Caused by Heterozygous Missen-Mutations in the SAM Domain of p63. Human Molecular Genetics, 10, 221-229. [Google Scholar] [CrossRef] [PubMed]
[22] Ianakiev, P., Kilpatrick, M., Poudiarskai, W., Basel, D., Beighton, P. and Tsipouras, P. (2000) Splithand/Split-Foot Malformation Is Caused by Mutations in the p63 Gene on 3q27. The American Journal of Human Genetics, 67, 59-66. [Google Scholar] [CrossRef] [PubMed]
[23] Westfall, M.D. and Pietenpol, J.A. (2004) P63: Molecular Complexity in Development and Cancer. Carcinogenesis, 25, 857-864. [Google Scholar] [CrossRef] [PubMed]
[24] Senoo, M., Pinto, F., Crum, C.P. and McKeon, F. (2007) p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia. Cell, 129, 523-536. [Google Scholar] [CrossRef] [PubMed]
[25] 咏梅, 赵诚. P63基因在口腔肿瘤中的研究进展[J]. 内蒙古医学院学报, 2012, 34(S6): 1006-1010.
[26] Chompret, A. (2001) The Li-Fraumeni Syndrome. Biochimie, 84, 75-82. [Google Scholar] [CrossRef] 
[27] Stanley, M. (2010) Pathology and Epidemiology of HPV Infection in Females. Gynecologic Oncology, 117, S5-S10. [Google Scholar] [CrossRef] [PubMed]
[28] Parish, J.L., Kowalczyk, A., Chen, H.T., Roeder, G.E., Sessions, R., Buckle, M., et al. (2006) E2 Proteins from High and Low Risk Human Papillomavirus Types Differ in Their Ability to Bind p53 and Induce Apoptotic Cell Death. Journal of Virology, 80, 4580-4590. [Google Scholar] [CrossRef] 
[29] Martens, J.E., Arends, J., Van der Linden, P.J., De Boer, B.A. and Helmerhorst, T.J. (2004) Cytokeratin 17 and p63 Are Markers of the HPV Target Cell, the Cervical Stem Cell. Anticancer Research, 24, 771-775.
[30] Quade, B.J., Yang, A., Wang, Y., Sun, D., Park, J., Sheets, E.E., et al. (2001) Expression of the p53 Homologue p63 in Early Cervical Neoplasia. Gynecologic Oncology, 80, 24-29. [Google Scholar] [CrossRef] [PubMed]
[31] Houghton, O. and McCluggage, W.G. (2009) The Expression and Diagnostic Utility of p63 in the Female Genital Tract. Advances in Anatomic Pathology, 16, 316-321. [Google Scholar] [CrossRef] 
[32] Garcia, M.T., Acar, B.C., Jorda, M., Gomez-Fernandez, C. and Ganjei-Azar, P. (2007) Use of p63 for Distinction of Glandular versus Squamous Lesions in Cervicovaginal Specimens. Cancer Cytopathology, 111, 54-57. [Google Scholar] [CrossRef] [PubMed]
[33] Mitildzans, A., Arechvo, A., Rezeberga, D. and Isajevs, S. (2017) Ex-pression of p63, p53 and Ki-67 in Patients with Cervical Intraepithelial Neoplasia. Turkish Journal of Pathology, 33, 9-16. [Google Scholar] [CrossRef] [PubMed]
[34] Lin, Z.H., Liu, M.Z., Li, Z.H., Kim, C., Lee, E. and Kim, I. (2006) ΔNp63 Protein Expression in Uterine Cervical and Endometrial Cancers. Journal of Cancer Research and Clinical Oncology, 132, 811-816. [Google Scholar] [CrossRef] [PubMed]
[35] Wang, T.Y., Chen, B.F., Yang, Y.C., Chen, H., Wang, Y., Cviko, A., Quade, B.J., Sun, D., Yang, A., McKeon, F.D. and Crum, C.P. (2001) Histologic and Immunophenotypic Classification of Cervical Carcinomas by Expression of the p53 Homologue p63: A Study of 250 Cases. Human Pa-thology, 32, 479-486. [Google Scholar] [CrossRef] [PubMed]
[36] Melar-New, M. and Laimins, L.A. (2010) Human Papillomaviruses Modulate Expression of MicroRNA 203 upon Epithelial Differentiation to Control Levels of p63 Proteins. Journal of Virology, 84, 5212-5221. [Google Scholar] [CrossRef] 
[37] Mighty, K.K. and Laimins, L.A. (2011) p63 Is Necessary for the Ac-tivation of Human Papillomavirus Late Viral Functions upon Epithelial Differentiation. Journal of Virology, 85, 8863-8869. [Google Scholar] [CrossRef] 
[38] Srivastava, K., Pickard, A., McDade, S. and McCance, D.J. (2017) p63 Drives Invasion in Keratinocytes Expressing HPV16 E6/E7 Genes through Regulation of Src-FAK Signalling. Oncotarget, 8, 16202-16219. [Google Scholar] [CrossRef] [PubMed]
[39] Kurita, T., Mills, A.A. and Cunha, G.R. (2004) Roles of p63 in the Diethylstilbestrol-Induced Cervicovaginal Adenosis. Development, 131, 1639-1649. [Google Scholar] [CrossRef] [PubMed]
[40] Allocati, N., Illo, C.D. and Laurenzi, V.D. (2012) p63/p73 in the Control of Cell Cycle and Cell Death. Experimental Cell Research, 318, 1285-1290. [Google Scholar] [CrossRef] [PubMed]
[41] Teissier, S., Ben Khalifa, Y., Mori, M., Pautier, P., Desaintes, C. and Thierry, F. (2007) A New E6/P63 Pathway, Together with a Strong E7/E2F Mitotic Pathway, Modulates the Transcriptome in Cervical Cancer Cells. Journal of Virology, 81, 9368-9376. [Google Scholar] [CrossRef] 
[42] Lin, Z., Nan, Y., Zhang, X., Zhao, Y., Kim, C. and Kim, I. (2006) Reverse Transcription-Polymerase Chain Reaction and Western Blotting Analysis for Detection of p63 Isoforms in Uterine Cervical Cancers. International Journal of Gynecological Cancer, 16, 1643-1647.
[43] Liu, X., Clements, A., Zhao, K. and Marmorstein, R. (2006) Structure of the Human Papillomavirus E7 Oncoprotein and Its Mechanism for Inactivation of the Retinoblastoma Tumor Suppressor. Journal of Biological Chemistry, 281, 578-586. [Google Scholar] [CrossRef] 
[44] Dyson, N. (1998) The Regulation of E2F by pRB-Family Proteins. Genes & Development, 12, 2245-2262. [Google Scholar] [CrossRef] [PubMed]

为你推荐